SILVERARC CAPITAL MANAGEMENT, LLC Celldex Therapeutics, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$0
portfolio value

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +46.67% 16.95K shares 519K $28.11 53.27K
Q3 2022 put Decrease -100.00% -36K shares -971K $28.11 0
Q2 2022 share Decrease -20.24% -9.21K shares 723K $26.96 36.32K
Q2 2022 put Increase 0.00% 36K shares 971K $26.96 36K
Q1 2022 share Increase +0.90% 406 shares -1.48M $34.06 45.53K
Q4 2021 share Increase +18.01% 6.88K shares -321K $38.9 45.13K
Q3 2021 share Increase +285.48% 28.32K shares -861K $53.99 38.24K
Q2 2021 share Increase 0.00% 9.92K shares 2.92M $33.44 9.92K
Q1 2021 share Decrease -100.00% -80.28K shares -1.40M $20.6 0
Q4 2020 share Increase 0.00% 80.28K shares 1.40M $17.52 80.28K